
Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings
Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会战略委员会工作细则(2025年12月) | 2025-12-23 | Chinese | |
| 董事会薪酬与考核委员会工作细则(2025年12月) | 2025-12-23 | Chinese | |
| 董事会秘书工作制度(2025年12月) | 2025-12-23 | Chinese | |
| 董事会可持续发展委员会工作细则(2025年12月) | 2025-12-23 | Chinese | |
| 内幕信息知情人登记制度(2025年12月) | 2025-12-23 | Chinese | |
| 突发事件处理制度(2025年12月) | 2025-12-23 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 35997289 | 董事会战略委员会工作细则(2025年12月) | 2025-12-23 | Chinese | ||
| 35997287 | 董事会薪酬与考核委员会工作细则(2025年12月) | 2025-12-23 | Chinese | ||
| 35997284 | 董事会秘书工作制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997280 | 董事会可持续发展委员会工作细则(2025年12月) | 2025-12-23 | Chinese | ||
| 35997277 | 内幕信息知情人登记制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997275 | 突发事件处理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997274 | 子公司管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997272 | 总裁工作细则(2025年12月) | 2025-12-23 | Chinese | ||
| 35997269 | 董事会审计委员会工作细则(2025年12月) | 2025-12-23 | Chinese | ||
| 35997264 | 外部信息使用人管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997261 | 信息披露管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997259 | 银行间债券市场债务融资工具信息披露管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997258 | 董事、高级管理人员所持公司股份及其变动管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997256 | 可持续发展管理制度(2025年12月) | 2025-12-23 | Chinese | ||
| 35997255 | 董事会提名委员会工作细则(2025年12月) | 2025-12-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Walvax Biotechnology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55154/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55154 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55154 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55154 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55154}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Walvax Biotechnology Co.,Ltd. (id: 55154)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.